Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.

Richie JP Jr, Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):783-90.

2.

Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).

Muscat JE, Djordjevic MV, Colosimo S, Stellman SD, Richie JP Jr.

Cancer. 2005 Apr 1;103(7):1420-6.

3.

Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.

Carmella SG, Borukhova A, Akerkar SA, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):113-20.

4.
5.

Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.

Derby KS, Cuthrell K, Caberto C, Carmella S, Murphy SE, Hecht SS, Le Marchand L.

Int J Cancer. 2009 Nov 15;125(10):2418-24. doi: 10.1002/ijc.24585.

6.

Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.

Xia Y, Bernert JT, Jain RB, Ashley DL, Pirkle JL.

Biomarkers. 2011 Mar;16(2):112-9. doi: 10.3109/1354750X.2010.533288. Epub 2010 Nov 29.

PMID:
21114376
7.

Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers.

Hecht SS, Chung FL, Richie JP Jr, Akerkar SA, Borukhova A, Skowronski L, Carmella SG.

Cancer Epidemiol Biomarkers Prev. 1995 Dec;4(8):877-84.

8.

Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.

Hecht SS, Carmella SG, Chen M, Dor Koch JF, Miller AT, Murphy SE, Jensen JA, Zimmerman CL, Hatsukami DK.

Cancer Res. 1999 Feb 1;59(3):590-6.

9.

Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse.

Upadhyaya P, Kenney PM, Hochalter JB, Wang M, Hecht SS.

Carcinogenesis. 1999 Aug;20(8):1577-82.

PMID:
10426810
10.

Effects of menthol on tobacco smoke exposure, nicotine dependence, and NNAL glucuronidation.

Muscat JE, Chen G, Knipe A, Stellman SD, Lazarus P, Richie JP Jr.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):35-41. doi: 10.1158/1055-9965.EPI-08-0744.

11.

Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.

Anderson KE, Carmella SG, Ye M, Bliss RL, Le C, Murphy L, Hecht SS.

J Natl Cancer Inst. 2001 Mar 7;93(5):378-81.

PMID:
11238699
12.

Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers.

Murphy SE, Carmella SG, Idris AM, Hoffmann D.

Cancer Epidemiol Biomarkers Prev. 1994 Jul-Aug;3(5):423-8.

13.

Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.

Kresty LA, Carmella SG, Borukhova A, Akerkar SA, Gopalakrishnan R, Harris RE, Stoner GD, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):521-5.

14.

Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.

Hecht SS, Murphy SE, Carmella SG, Zimmerman CL, Losey L, Kramarczuk I, Roe MR, Puumala SS, Li YS, Le C, Jensen J, Hatsukami DK.

J Natl Cancer Inst. 2004 Jan 21;96(2):107-15.

PMID:
14734700
15.

Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children.

Hecht SS, Ye M, Carmella SG, Fredrickson A, Adgate JL, Greaves IA, Church TR, Ryan AD, Mongin SJ, Sexton K.

Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1109-16.

16.
17.

Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.

Carmella SG, Le Ka KA, Upadhyaya P, Hecht SS.

Chem Res Toxicol. 2002 Apr;15(4):545-50.

PMID:
11952341
18.

Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.

Chen G, Luo S, Kozlovich S, Lazarus P.

Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1175-1184. doi: 10.1158/1055-9965.EPI-15-1245. Epub 2016 May 9.

19.

Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers.

Stepanov I, Upadhyaya P, Carmella SG, Feuer R, Jensen J, Hatsukami DK, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1764-73. doi: 10.1158/1055-9965.EPI-07-2844.

Supplemental Content

Support Center